Related Experiment Video
Updated: Jun 1, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Prolonged corrected QT dispersion
M Orditura1, B Sarubbi, F Devita
1UNIV NAPLES,SCH MED 2,DEPT INTERNAL & EXPT MED F MAGRASSI,I-80138 NAPLES,ITALY. UNIV NAPLES,SCH MED 2,DIV MED ONCOL,CHAIR CARDIOL,I-80138 NAPLES,ITALY.
Abstract:
The anthracyclines are antibiotics effective in the treatment of many malignancies. However, their usefulness is limited by the development of potentially acute or chronic cardiotoxicity. No definitive guidelines exist for monitoring cardiac function during and after anthracyclines although methods have been suggested. Electrocardiograms and echocardiograms are routinely utilized for noninvasive assessment of myocardial function. The aim of the study was to assess the effects of doxorubicin on ventricular repolarization time indexes, as they have been shown to be effective in the identification of electrical myocardial instability and hence in the identification of the risk for either arrhythmia or heart failure. Electrocardiographic parameters were compared in 27 cancer patients before and after chemotherapy including doxorubicin. The data of the present study show that after only a short period of treatment with doxorubicin there is a significant increase in ventricular recovery time indexes (QTc dispersion and 'Adjusted' QTc dispersion). The relation between the electrophysiological response to doxorubicin and the potential cardiotoxic effect of this drug remains to be established through prospective studies.
Related Concept Videos
Pharmacodynamic Models: Linear Concentration–Effect Model
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
